药物合物的链接器的最新进展
Shirui Deng1, Xiaoan Wen1, Jinzheng Wang2
1School of China Pharmaceutical University, Nanjing, China.
Current medicinal chemistry
|September 18, 2024
概括
药物合物通过提高药物的疗效和减少副作用来增强癌症治疗. 连接器的稳定性和裂变是它们有针对性的作用和治疗潜力的关键.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 药物运输 药物运输 药物运输
背景情况:
- 药物合物在向癌症治疗中至关重要.
- 它们充当前药物,改善治疗指数并最大限度地减少副作用.
- 连接器的稳定性和选择性裂变对于有效性至关重要.
研究的目的:
- 根据裂变机制,审查和分类药物合联结剂.
- 总结各种可切割链接器的化学特性,好处和缺点.
- 突出具有发展潜力的特定链接类型.
主要方法:
- 文献综述和可切割链接器的分类.
- 分析化学性质,优势和局限性.
- 案例研究说明了链接器应用程序.
主要成果:
- 根据切割方式对连接器的分类.
- 详细概述各种可切割链接器特性.
- 确定未来药物合物开发的有希望的链接器.
结论:
- 可切割链接剂是有效药物合物的必不可少的组成部分.
- 了解链接器属性指导着向癌症治疗的设计.
- 这一审查为选择和开发最佳链接器提供了一个框架.
更多相关视频
09:12Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
6.9K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.7K
相关概念视频
Phase II Conjugation Reactions: Overview
172
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
172
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
186
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
186
Conjugate Addition (1,4-Addition) vs Direct Addition (1,2-Addition)
3.1K
α,β-Unsaturated carbonyl compounds with two electrophilic sites, the carbonyl carbon, and the β carbon, are susceptible to nucleophilic attack via two modes: conjugate or 1,4-addition and direct or 1,2-addition.
Conjugate addition results in a thermodynamically stable product. The reaction retains the stronger C=O bond at the expense of the weaker C=C π bond. The process is slow as the β carbon is less electrophilic than the carbonyl carbon.
Direct addition products are...
Conjugate addition results in a thermodynamically stable product. The reaction retains the stronger C=O bond at the expense of the weaker C=C π bond. The process is slow as the β carbon is less electrophilic than the carbonyl carbon.
Direct addition products are...
3.1K
Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K
